Skip to content
value.today

Conexeu Sciences Inc.

🇺🇸 Reno, Nevada, USABiotechnologyFounded 2022
Total raised
$8 M
4 rounds on record
Latest round
$2 M
Oct 2026
First round on record
Apr 2025
Today
Went public
See the company page

Conexeu Sciences Inc. is listed today as Conexeu Sciences Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Conexeu Sciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2026$2 MNo. 4Under $2 million

Conexeu Sciences Inc.: Raise no. 4, Oct 2026

Investors in this round

2 investors had bought by the notice of Oct 21, 2026: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brian Pilcher · Executive Officer
  • Claudia Chavez-Munoz · Executive Officer
  • David R Bogart · Executive Officer, Director
  • Miles Harrison · Executive Officer, Director
  • Stephen D Inouye · Executive Officer
  • Aaron Farberg · Director
  • Ana Bastiani-Posner · Director
  • Andrew Costa · Director
  • April Burke · Director
  • Jeff Sharpe · Director
  • Sebastian Purcell · Director
  • Z Paul Lorenc · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount equals the price of units (499,999 units @ $3.00), plus aggregate exercise price of the warrants forming part of the units (499,999 warrants @ $3.00).”

Signed by Stephen Inouye, Cfo. Source: SEC Form D, newest notice filed Oct 21, 2026. Read the notice at the SEC.

equity, optionsSEC
Mar 2026$2 MNo. 3Under $2 million

Conexeu Sciences Inc.: Raise no. 3, Mar 2026

Investors in this round

8 investors had bought by the notice of Apr 1, 2026: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brian Paul Pilcher · Executive Officer
  • Claudia D Chavez-Munoz · Executive Officer
  • Miles R Harrison · Executive Officer, Director
  • Stephen D Inouye · Executive Officer
  • Aaron R Farberg · Director
  • David R Bogart · Director
  • Jeff D Sharpe · Director
  • Sebastian Paul Purcell · Director
  • Z Paul Lorenc · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount equals the price of 453,750 common shares at $4.00 per share.”

Signed by Stephen Inouye, Cfo. Source: SEC Form D, newest notice filed Apr 1, 2026. Read the notice at the SEC.

equitySEC
Oct 2025$3 MNo. 2$2 to $10 million

Conexeu Sciences Inc.: Raise no. 2, Oct 2025

Investors in this round

5 investors had bought by the notice of Nov 13, 2025: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brian Paul Pilcher · Executive Officer
  • Claudia D Chavez-Munoz · Executive Officer
  • Miles R Harrison · Executive Officer, Director
  • Stephen D Inouye · Executive Officer
  • Aaron R Farberg · Director
  • David R Bogart · Director
  • Jeff D Sharpe · Director
  • Sebastian Paul Purcell · Director
  • Z Paul Lorenc · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount equals aggregate price of 869,566 shares at $2.30 per share and 460,722 shares at $2.00 per share.”

Signed by Jeff Sharpe, Director. Source: SEC Form D, newest notice filed Nov 13, 2025. Read the notice at the SEC.

equitySEC
Apr 2025$1 MNo. 1Under $2 million

Conexeu Sciences Inc.: Raise no. 1, Apr 2025

Investors in this round

18 investors had bought by the notice of Jul 2, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Brian R Pilcher · Executive Officer, Director
  • Claudia D Chavez-Munoz · Executive Officer
  • Jeff D Sharpe · Executive Officer, Director
  • Stephen D Inouye · Executive Officer
  • David R Bogart · Director
  • Michael R Wright · Director
  • Z Paul Lorenc · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount equals the aggregate price of 19,012,070 shs @ a price between $0.00000289 to $0.20/sh, plus the aggregate exercise price of 957,334 wts @ $0.18/sh, 1,496,880 wts @ $0.187/sh, 3,362,000 wts @ $0.20/sh and 600,000 options @ $0.20/sh.”

Signed by Jeff Sharpe, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 2, 2025. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Conexeu Sciences Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2026).

    SEC Form D · Oct 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2026

That is all the official record says: Conexeu Sciences Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Conexeu Sciences Inc. are on record.

Investors#

No investor of Conexeu Sciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 18 investors.

Largest shareholders today

Institutions holding Conexeu Sciences Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Conexeu Sciences Inc.
NameRoleNamed in
Brian PilcherExecutive officerOct 2026
Claudia Chavez-MunozExecutive officerOct 2026
David R BogartExecutive officerOct 2026
Miles HarrisonExecutive officerOct 2026
Brian Paul PilcherExecutive officerApr 2026
Claudia D Chavez-MunozExecutive officerApr 2026
Miles R HarrisonExecutive officerApr 2026
Stephen D InouyeExecutive officerApr 2026
Brian R PilcherExecutive officerJul 2025
Jeff D SharpeExecutive officerJul 2025
Claudia D StephenExecutive officerMay 2025
Michael R WrightExecutive officerMay 2025
Aaron FarbergDirectorOct 2026
Ana Bastiani-PosnerDirectorOct 2026
Andrew CostaDirectorOct 2026
April BurkeDirectorOct 2026
Jeff SharpeDirectorOct 2026
Miles HarrisonDirectorOct 2026
Sebastian PurcellDirectorOct 2026
Aaron R FarbergDirectorApr 2026
David R BogartDirectorApr 2026
Jeff D SharpeDirectorApr 2026
Miles R HarrisonDirectorApr 2026
Sebastian Paul PurcellDirectorApr 2026
Z Paul LorencDirectorApr 2026
Brian R PilcherDirectorJul 2025
Michael R WrightDirectorJul 2025

Went public since 2026. Its SEC number is that of a company listed on a stock exchange.